Adjuvant therapy in patients with clinical T2N0 rectal cancer may currently be underutilized, according to the findings of a study from researchers at @TempleUniv Hospital and Fox Chase. Read more from Simran Kripalani, MD, first author on the study: https://t.co/4QgnsWJauq
In a study presented at DDW by first author Maryclare Taylor, MD, pancreatic cancer patients who received single modality neoadjuvant therapy experienced fragmented care more often compared with those who received total neoadjuvant therapy: https://t.co/Ny4r2gptLj
👋 New to @AcademicSurgery and excited to contribute it’s mission in any way I can! Please consider my application for the Academic Advancement Committee at the AAS. Vote here!
https://t.co/osUpDU39vI #ElectMyAAS via @AcademicSurgery@TempleSurgery
How else would my family pretend I was there for vacations I had to miss if they couldn’t print out a picture of me in a swimsuit off of Facebook and plaster it to a boogie board?? #MedBikini
White privilege is very very real. And it’s not fair. I’m listening, I’m learning, and I am committing to continue to act for change. Black lives matter.